Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
2018 · New England Journal of Medicine · 2,782 citations
https://doi.org/10.1056/nejmoa1716153
P
P. James B. Dyck
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
757
Papers
45.1K
Citations
107
h-index
456
i10-index
P. James B. Dyck is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Peripheral Neuropathies and Disorders & Botulinum Toxin and Related Neurological Disorders & Hereditary Neurological Disorders. The author has an h-index of 107, co-authored 644 publications.
ORCID: 0000-0003-0212-8254Papers by this author
worksDiagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
2015 · Journal of the American College of Cardiology · 468 citations
https://doi.org/10.1016/j.jacc.2015.09.075
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial
2010 · Muscle & Nerve · 230 citations
https://doi.org/10.1002/mus.21661
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial
2010 · Muscle & Nerve · 230 citations
https://doi.org/10.1002/mus.21661
History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation
2005 · Journal of the Peripheral Nervous System · 207 citations
https://doi.org/10.1111/j.1085-9489.2005.0010206.x
History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation
2005 · Journal of the Peripheral Nervous System · 207 citations
https://doi.org/10.1111/j.1085-9489.2005.0010206.x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat